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Acute Kidney Injury S97Conclusion: BMI is an independent risk factor for AKI after cardiac surgery,
the AKI incidence increased, as BMI gained. The hospital prognosis of AKI and
AKI-RRT were optimum, when BMI was 24e28 kg/m2.http://dx.doi.org/10.1016/j.hkjn.2015.09.065
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Role of SIRT1 in Study of Renal Ischemia-Reperfusion Injury and Its
Effect on NF-kBp65-PGC-1a Signal Pathway In Mice
Lu Li, Ying Zhang, Zhongcheng Yin
The Affiliated Hospital of Xuzhou Medical College, Xuzhou, China
Objective: To investigate the role of silent mating type information regula-
tion 2 homologue 1 (SIRT1) in renal ischemia-reperfusion (IR) injury and its
effect on nuclear factor-kB (NF-kBp65)-peroxisome proliferator-activated
receptor gamma coactivator 1 alpha (PGC-1a) signal pathway in mice.
Methods: Animal models of renal ischemia-reperfusion injury were established
in a total of 90 healthy male C57BL/6 mice. Determination techniques included
routine biochemical methods for the levels of serum creatinine and blood urea
nitrogen (BUN), spectrophotometry for the level of superoxide dismutase
(SOD), H-E staining for the histological changes as well as immunohistochemical
and Western blotting analyses for the expressions of SIRT1, NF-kBp65 and PGC-
1a, respectively.
Results: Comparedwith that in control and sham-operated groups, the levels of
serum creatinine and BUNwere higher and SOD level in renal tissues were lower
at 12 h and 24 h after operation in IR groups (P < 0.05). H-E staining revealed
evident pathological lesions including necrosis of renal tubular epithelial cells
in IR groups. Comparedwith the corresponding IR group, resveratrol attenuated
the above-mentioned changes (P < 0.05) while EX527 aggravated those
(P< 0.05). BothWestern blotting and immunohistochemistry revealed the upre-
gulated SIRT1 expression and the activated NF-kB signal pathway, the upregu-
lated p65 expression and the downregulated PGC-1a expression subsequent to
IR (P < 0.05). The expressions of SIRT1 and PGC-1a in resveratrol group were
upregulatedcomparedto that in IRgroup (P< 0.05)and theNF-kBp65expression
was downregulated (P< 0.05).While the SIRT1and PGC-1a expressions in EX527
group were downregulated compared to that in IR group (P< 0.05) and the NF-
kBp65 expression was upregulated (P < 0.05).
Conclusion: In mouse model of renal ischemia-reperfusion injury, the acti-
vation of SIRT1 could inhibit the NF-kBp65 expression and accordingly upre-
gulated PGC-1a level, contributing to inhibited inflammatory reactions and
attenuated oxidative stress-induced injury in the protection of the kidneys.http://dx.doi.org/10.1016/j.hkjn.2015.09.066
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Vicious Circle of NLRP3 and Mitochondrial Damage Plays Central Role in
Renal Ischemia-Reperfusion Injury
Liu Y. R., Wen Yi, Tang T. T., Liu B. C.
Southeast University, Nanjing, China
Background: Tubular epithelial cells dysfunction and loss play a critical role
in the evolution of ischemia AKI. Recent work suggested that mitochondrial
damage and NLRP3 inflammasome activation are important drivers of AKI-
associated pathology. And TXNIP, an endogenous inhibitor of the antioxidant
thioredoxin and reactive oxygen species (ROS) sensor, may has a role in
activing NLRP3 inflammasome.
Methods: C57BL/6J and NLRP3-/- male mice were subject to 30 minutes of
ischemia and 1, 3 and 7 days of reperfusion. We used mito-TEMPO, mitochon-
dria-targeted antioxidant, to investigate whether NLRP3 inflammasome activa-
tion could be inhibitedby reducingmitochondrial derivedROS (mROS). Themice
were then sacrificed 1 day, 3 days or 7 days after renal ischemia reperfusion
injury, and blood and tissues were harvested. In vitro study, we used a tubular
epithelial cell line (HK-2). Cells were incubated for 1, 3, 6 or 9 hours of hypox-
ia-hypoglycemic plus 2 hours of normoxia/normal-glucose incubation. Oxygen-
glucose deprivation injury occurred by placing cells in a hypoxic environment
(1% O2/5% CO2/94% N2) in the presence of glucose-free DMEM medium for 1, 3,
6 or 9 hours.Mitochondrial damage and the activation of NLRP3weremeasured.
Results: In this study,weestablishedan ischemiareperfusion induced-AKImodel
characterized by tubular epithelial cells damage, mitochondria dysfunctionwhich leaded to the excessive production of mROS. The renal expression levels
of the NLRP3, IL-1b and IL-18 were significantly increased in this animal model.
However, Kidney dysfunction andmitochondrial damage were attenuated obvi-
ously in NLRP3-/- mice compared with WT mice with ischemia AKI. In vitro, ox-
ygen-glucose deprivation injury timely dependently increased the expression
levels of NLRP3 inflammasome axis. The mitochondrial injury in damaged HK2
cells was also suppressed by silencing NLRP3 and caspase1.
S98 Acute Kidney InjuryConclusion: Mito-TEMPO could restore mitochondrial function and dissoci-
ating TXNIP from NLRP3 to inhibit NLRP3 inflammasome activation. TXNIP
siRNA also decreased NLRP3 activation significantly in HK2 cells during oxy-
gen-glucose deprivation injury.http://dx.doi.org/10.1016/j.hkjn.2015.09.067
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Sirolimus Attenuates Renal IschemiaeReperfusion Injury and
Subsequent Regeneration of Tubular Epithelial Cells in a Rat Model
Zhigang Wang, Baoping Chen
Huaihe Affiliated Hospital of Henan University, Kaifeng, Henan, China
Objective: To evaluate the attenuation of renal ischemiaereperfusion (I/R)
injury and subsequent regeneration of tubular epithelial cells with sirolimus
treatment in a rat model.
Methods: Ninety male rats were randomized into five groups of 18 rats each:
a sham group, a control group (I/R without immunosuppression), and three
sirolimus treatment groups (I/R with pre- and postoperative sirolimus treat-
ment, via gastric gavage, at 1, 3, and 5 mg/kg/d in respective groups). I/R
injury was induced by occlusion (for 45 minutes) and reperfusion of the
left renal artery, the right kidney was removed upon reperfusion of the
left renal artery. Levels of sirolimus, serum creatinine, b2-microglobulin
(b2-MG), neutrophil gelatinase-associated lipocalin (NGAL), interleukin-18
(IL-18), and hepatocyte growth factor (HGF) were assessed from blood sam-
ples by ELISA; expression of Fas and Bcl-2, proliferating cell nuclear antigen
(PCNA), HGF, bone morphogenetic protein-7 (BMP-7), as well as other indica-
tors and rate of apoptosis were determined by immunohistochemical, West-
ern blot, PCR, and TUNEL assays; and histopathologic changes were observed
in H&E-stained sections of renal tissue for pathologic scoring.
Results: Indicators of renal injury (serum creatinine, b2-MG, IL-18, Fas, and
pathologic scoring) were lower in irolimus-treated groups (dose-dependent
change) versus the control group at 1, 3, and 7 days after I/R injury as
were indicators of tissue repair (HGF, Bcl-2, BMP-7, PCNA); however, Bcl-2
and NGAL levels were upregulated in the sirolimus-treated groups versus
sham and control groups (P < 0.05 for all). Effects on apoptosis were marked
in the group treated with the highest sirolimus dose (5 mg/kg/d) compared
with the other four groups. Cell proliferation was lower in the treatment
groups versus the control group.
Conclusion: Sirolimus has dose-dependent renoprotective and anti-
apoptotic effects in early-stage I/R injury to the kidney; it can also downre-
gulate repair of tubular epithelial cell by its effect on cell proliferation.http://dx.doi.org/10.1016/j.hkjn.2015.09.0680226
Clinical Characteristics of Acute Kidney Injury in Community-acquired
and Hospital-acquired Patients in Xinjiang
Suhua Li, Mingming Qiao, Shun Wang, Caichang Li, Li Zhang, Jian Liu
The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
Objective: The aim of present study was to compare clinical characteristics
between community-acquired acute kidney injury (CA-AKI) and hospital-ac-
quired acute kidney injury (HA-AKI) patients in Xinjiang.
Methods: The study used the hospital network system to screen the clinical
data on adult patients in the First Affiliated Hospital in Xinjiang Medical Uni-
versity from January to July 2013. A total 19,528 patients were screened,
544 AKI patients were enrolled based on KIDGO AKI guidelines. 330 patients
were included in HA-AKI group and 214 patients in CA-AKI group. Clinical var-
iables including mortality were analyzed retrospectively.
Results: The mean age in CA-AKI group was significantly older than HA-AKI
group, 62.9 16.8 years vs. 56.6 15.9 years. The incidence of AKI in hospi-
talized patients was 2.8% (544/19,528), among them, CA-AKI group was 1.7%
and HA-AKI group was 1.1%. The comorbid diseases were cardiac disease, hy-
pertension, diabetes and chronic liver disease. The majority of AKI was
caused by pre-renal etiologies including acute blood loss, low plasma vol-
ume, and low cardiac output. The length of hospitalized days was signifi-
cantly shorter in CA-AKI group compared to HA-AKI group, 16.7 15.1 daysvs. 23.6 17.9 days. All-cause mortality was significantly lower in CA-AKI
group compared to HA-AKI group, 11.9% vs. 20.5%. Results by multivariate lo-
gistic regression model analysis demonstrated the common independent risk
factors of AKI in both groups were ICU hospitalization and shock. The inde-
pendent risk factor of AKI in CA-AKI group was diabetes (OR Z 2.323). In
contrast, the independent risk factors of AKI in HA-AKI group were elderly
(OR Z 3.303), oliguria (OR Z 6.906), use of anti-inflammatory drugs (OR
Z 13.079) and multiple organ dysfunction syndrome (OR Z 17.778).
Conclusion: Present study revealed majority AKI either community-ac-
quired or hospital-acquired were caused by pre-renal etiologies. All-cause
mortality was lower in community-acquired AKI compared to hospital-ac-
quired AKI. The independent risk factors were different between CA-AKI
and HA-AKI.http://dx.doi.org/10.1016/j.hkjn.2015.09.069
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Protective Effects of Recombinant Human Erythropoietin Combined
with Alprostadil in Treatment of Acute Kidney Injury
Bin Liu, Y. L. Sun
Affiliated Calmette Hospital of Kunming Medical University, Kunming,
Yunnan, China
Objective: To investigate the protective effects of recombinant human
erythropoietin (rHuEPO) combined with alprostadil in treatment of acute
kidney injury (AKI).
Methods: A total of 120 hospitalized patients in June 2009 to October 2013
with AKI were randomly divided into four groups: control groupdhemodial-
ysis (HD) treatment; rHuEPO groupdHD with rHuEPO (3000 u, tiw); alprosta-
dil groupdHD with alprostadil (20 ug, qd); combined treatment groupdHD,
rHuEP (3000 u, tiw) and alprostadil (20 ug, qd), using medicine for 14 days.
Recording theoliguric stage, checking serum creatinine and urinary NGAL/IL-
18 at 4, 8 and 15 days.
Results: (1) The combined treatment group of oliguric stage is the shortest
(5 0.8 days) compared with the other three groups (P < 0.05). With the
extension of treatment time each Scr declined, the combined treatment
group is the most obvious, with control group has statistically significant dif-
ference (P < 0.05). (2) The urine NGAL of the control group was higher than
the other three groups (P < 0.05). EPO group and alprostadil group were
close, but were higher than the combined treatment group, with statistically
significant difference (P < 0.05). The urine IL-18 of the control group was
higher than in the other three groups (P < 0.05).
Conclusion: rHuEPO and alprostadilin treatment of acute kidney injury is
effective. rHuEPO combined with alprostadil in treatment of acute kidney
injury can shorten oliguric stage, improving renal function effectively.http://dx.doi.org/10.1016/j.hkjn.2015.09.070
